Common Stock, Shares, Outstanding of XBiotech Inc. from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
XBiotech Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • XBiotech Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 30,487,731, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

XBiotech Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 30,487,731 0 0% 31 Dec 2025 10-K 13 Mar 2026 2025 FY
Q3 2025 30,487,731 +8,325 +0.03% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 30,487,731 +24,575 +0.08% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 30,487,731 +36,850 +0.12% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 30,487,731 +50,767 +0.17% 31 Dec 2024 10-K 13 Mar 2026 2025 FY
Q3 2024 30,479,406 +42,442 +0.14% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 30,463,156 +27,442 +0.09% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 30,450,881 +11,606 +0.04% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 30,436,964 -2,311 -0.01% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 30,436,964 -2,313 -0.01% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 30,435,714 -3,561 -0.01% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 30,439,275 0 0% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 30,439,275 0 0% 31 Dec 2022 10-K 15 Mar 2024 2023 FY
Q3 2022 30,439,277 +41,466 +0.14% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 30,439,275 +415,268 +1.4% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 30,439,275 +456,474 +1.5% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 30,439,275 +1,134,879 +3.9% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 30,397,811 +1,173,273 +4% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 30,024,007 +1,126,613 +3.9% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 29,982,801 +1,129,874 +3.9% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 29,304,396 -12,215,237 -29% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 29,224,538 -11,841,929 -29% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 28,897,394 -12,106,266 -30% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 28,852,927 -7,237,198 -20% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 41,519,633 +5,619,861 +16% 31 Dec 2019 10-K 16 Mar 2021 2020 FY
Q3 2019 41,066,467 +5,246,695 +15% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 41,003,660 +5,183,888 +14% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 36,090,125 +570,353 +1.6% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 35,899,772 +460,500 +1.3% 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q3 2018 35,819,772 +382,000 +1.1% 30 Sep 2018 10-Q 31 Oct 2018 2018 Q3
Q2 2018 35,819,772 +400,000 +1.1% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 35,519,772 +304,550 +0.86% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 35,439,272 +2,811,581 +8.6% 31 Dec 2017 10-K/A 15 Mar 2019 2018 FY
Q3 2017 35,437,772 +2,993,980 +9.2% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 35,419,772 +2,991,096 +9.2% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 35,215,222 +2,923,116 +9.1% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 32,627,691 +348,585 +1.1% 31 Dec 2016 10-K 16 Mar 2018 2017 FY
Q3 2016 32,443,792 +390,827 +1.2% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 32,428,676 +387,712 +1.2% 30 Jun 2016 10-Q 12 Aug 2016 2016 Q2
Q1 2016 32,292,106 +4,565,475 +16% 31 Mar 2016 10-Q 13 May 2016 2016 Q1
Q4 2015 32,279,106 +4,732,474 +17% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q3 2015 32,052,965 30 Sep 2015 10-Q 13 Nov 2015 2015 Q3
Q2 2015 32,040,964 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 27,726,631 31 Mar 2015 10-Q 18 Jun 2015 2015 Q1
Q4 2014 27,546,632 31 Dec 2014 10-K 15 Apr 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.